BridgeMD
New treatment option for Von Willebrand Diseases
Official title Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
ClinicalTrials.gov ID: NCT04119908
What this study is testing
What is blood sample?
blood sample is an investigational medicine, being studied as a potential treatment for von willebrand diseases.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In Willebrand disease, there is currently no test available to identify non-invasively patients with a high risk of bleeding from angiodysplasias The study propose to use a sublingual capillary bed analysis by video-microscopy, a sensitive, reproducible and non-invasive technique, to assess whether sublingual capillary density is predictive of hemorrhagic risk for patients with von Willebrand disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patient with a significant form of von Willebrand disease (according to the of the Willebrand Disease French Reference Center), a Glanzmann...
- Social insured patient
You likely can't join if
- Minor patient
- Refusal of consent
- Person benefiting from a system of legal protection
- Pregnant patient
The study team makes the final eligibility decision.
Where it's taking place
- Lille, Nord, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, Nord, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.